Stifel Financial
PYXS icon

Stifel Financial’s Pyxis Oncology PYXS Stock Holding History

Stifel Financial’s Portfolio PYXS Stock Details PYXS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$212K Buy
70,437
+19,900
+39% +$38.1K ﹤0.01% 3478
2026
Q1 		$73.8K Buy
+50,537
New +$76.2K ﹤0.01% 3560

Other funds holding PYXS

GGI
GordonMD Global Investments Beverely Hills, California $207M AUM
P
Pfizer New York $170M AUM 191.09% 1-Year Est. Return
LCM
Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
HP
HealthInvest Partners Stockholm, Sweden $372M AUM 59.89% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Stifel Financial's PYXS Position: Q2 2026 in Review

Stifel Financial increased its Pyxis Oncology (PYXS) stake by 39% in Q2 2026, buying an estimated $38.1K and bringing the position to 70,437 shares worth $212K. The position accounts for ﹤0.01% of the portfolio, ranked #3478.

Stifel Financial first reported a position in PYXS in Q1 2026 and has held it in 2 quarters since. 76 funds tracked by Wall St. Rank hold PYXS as of Q2 2026.

  • Stifel Financial held 70,437 shares of Pyxis Oncology worth $212K as of Q2 2026.
  • Stifel Financial bought 19,900 Pyxis Oncology shares in Q2 2026, an estimated $38.1K.
  • Pyxis Oncology made up ﹤0.01% of Stifel Financial's portfolio in Q2 2026, its #3478 holding.
  • Stifel Financial first reported a position in Pyxis Oncology in Q1 2026 and has held it in 2 quarters since.
  • 76 funds tracked by Wall St. Rank held Pyxis Oncology as of Q2 2026.

Based on Stifel Financial's 13F filing for Q2 2026, filed 12 Aug 2026.